Virtual World Training for Community Health Workers (CHW)

Sponsor
University of Delaware (Other)
Overall Status
Completed
CT.gov ID
NCT04161846
Collaborator
University of Illinois at Chicago (Other)
26
1
2
20.6
1.3

Study Details

Study Description

Brief Summary

Standard, effective, and scalable training models are needed to help equip community health workers in their community-based diabetes prevention awareness efforts. This study will tailor/adapt, implement, and evaluate an innovative internet-based virtual world model to remotely deliver a diabetes prevention awareness training program to community health workers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Virtual Training
  • Behavioral: In Person Training
N/A

Detailed Description

Standard, effective, and scalable training models are needed to help equip community health workers in their community-based diabetes prevention awareness efforts. This study will tailor/adapt, implement, and evaluate an innovative internet-based virtual world model to remotely deliver a diabetes prevention awareness training program to community health workers. A sequential mixed-methods design is used to address these specific aims: 1. Use community-based participatory research methods to guide the overall study and inform tailoring and adaptation of our virtual world model to deliver the CHW training program; 2. Conduct a randomized pilot study to compare change in primary outcomes (0, 12 weeks) after the in-person versus virtual world delivery of the program; and 3. Conduct summative focus groups to gather information to refine the program and study methodology.

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized 2 group repeated measures design (Pre-Pandemic) [Pandemic modification: Only Virtual world group]Randomized 2 group repeated measures design (Pre-Pandemic) [Pandemic modification: Only Virtual world group]
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Reaching Racial/Ethnic Minority Communities to Support Healthy Lifestyle Change: Virtual World Training for Community Health Workers
Actual Study Start Date :
Aug 8, 2019
Actual Primary Completion Date :
Apr 25, 2021
Actual Study Completion Date :
Apr 25, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual World Program

Participants take part in a group training delivered using a virtual world approach.

Behavioral: Virtual Training
The intervention involves a CHW training focused on raising awareness of diabetes prevention in the community. It is delivered remotely over 10 weeks using an internet based approach.

Active Comparator: In Person Program

Participants take part in a group training delivered using an in person approach.

Behavioral: In Person Training
The intervention involves a CHW training focused on raising awareness of diabetes prevention in the community. It is delivered in person over 10 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in content knowledge will be measured using the program Knowledge Questionnaire [Following program completion (10-12 weeks)]

    Program content knowledge will be assessed using an adapted version of the original training program knowledge questionnaire. Scores represent the number of content questions answered correctly. Higher scores represent greater program knowledge.

  2. Post Training Presentation Delivery Skills [Following program completion (10-12 weeks)]

    Each CHW will be asked to prepare and deliver a brief presentation, including 3 standardized topic areas.

Secondary Outcome Measures

  1. Change in Lifestyle Habits [Following program completion (10-12 weeks)]

    Eating habits will be assessed using the Visually-Enhanced Food Behavior Checklist.

  2. Change in Physical Activity [Following program completion (10-12 weeks)]

    Physical activity will be assessed with International Physical Activity Questionnaire (IPAQ).

Other Outcome Measures

  1. Change in self-efficacy and Stage of Change. A Self-Efficacy Index will be used and Stage of Change individual questions will be used for healthy eating and physical activity. [Following program completion (10-12 weeks)]

    A multi-item index of self-efficacy will be used to examine confidence in making lifestyle changes and in delivering the content. Higher scores represent greater confidence. Stage of change questions will assess CHW motivation (i.e., pre-contemplation, contemplation, preparation) or achievement of eating habit and physical activity behaviors (i.e., action/maintenance stages).

  2. Adherence [During training sessions (up to 10 weeks).]

    Attendance will be measured by a count of the number of training sessions attended.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • community health worker

  • 18-65 years old

  • Female

  • Of African American/Black/African ancestry

  • not getting 150 minutes of physical activity weekly and/or overweight

  • residing in Chicago/driving distance to Chicago study site

  • regular access to internet and computer

Exclusion Criteria:

• does not meet inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 UIC College of Nursing Chicago Illinois United States 60612

Sponsors and Collaborators

  • University of Delaware
  • University of Illinois at Chicago

Investigators

  • Principal Investigator: Laurie Ruggiero, Ph.D, University of Delaware

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laurie Ruggiero, Ph.D., Professor, University of Delaware
ClinicalTrials.gov Identifier:
NCT04161846
Other Study ID Numbers:
  • 1106606-8
First Posted:
Nov 13, 2019
Last Update Posted:
Jun 9, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 9, 2021